Project Grant S10OD034213
Award Date
9/15/23
Completion Date
9/14/24
Dollars Obligated
$161K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) under CFDA 93.351 provides $2,000,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to replace the 14T high-field vertical-bore NMR spectrometer and microimager. This specialized biomedical research equipment has been a central facility supporting numerous NIH-funded projects and training at MGH over the past four decades. The...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
The U.S. Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $1,140,766 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2024 through August 31, 2027, will fund a novel mHealth balance assessment and rehabilitation project using computer vision and AI for patients with neurofibromatosis type 2 (NF2). MGH, as the primary research institution, will...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
The Department of the Army Medical Command has awarded a $1,644,309 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The award, which runs from February 1, 2025, to January 31, 2028, will fund research aimed at "FUNCTIONAL MOLECULAR NETWORKS MODIFYING HIF2A ACTIVITY IN VHL TUMORS." As a renowned academic medical center and major recipient of federal...
This Project Grant award, valued at $1,618,114.00 and effective from April 1, 2025 to March 31, 2028, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports research conducted by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to define the role of anti-nephrin antibodies in the recurrence of focal segmental glomerulosclerosis post transplantation. This...
This $334,000 Project Grant award from the Department of Defense (DOD) Defense Health Agency supports research by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to analyze extracellular vesicles in exhaled breath condensates for the diagnosis and monitoring of pulmonary fibrosis. The research project, funded under the DOD's Military Medical Research and Development program (CFDA 12.420), aims to develop improved diagnostic and monitoring capabilities...
The General Hospital Corporation, doing business as Massachusetts General Hospital, was awarded a $302,801 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from September 1, 2022 to August 31, 2025 to advance a tissue oxygenation measurement device and evaluate galectin-3 as novel noninvasive prognostic biomarkers for monitoring vascularized composite...